Indeed, daily glucocorticoid therapy might dampen IL-2R expression and signaling to favor Th17 differentiation and/or expansion, particularly in the setting of weak T cell stimulation, such as during subclinical airways infection with microbes such as Haemophilus, which is associated with severe asthma (43). Here, IL2RA is linked to asthma.